Comparative efficacy of different acute reperfusion therapies for acute ischemic stroke: A comprehensive benefit-risk analysis of clinical trials

Brain and Behavior

Volumn 4, Issue 6, 2014, Pages 789-797

  Tsivgoulis, Georgios ^a,b,c   Alleman, John ^d   Katsanos, Aristeidis H ^e   Barreto, Andrew D ^f   Kohrmann, Martin ^g   Schellinger, Peter D ^h   Molina, Carlos A ⁱ   Alexandrov, Andrei V ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^d Cerevast Therapeutics Inc ^*  (United States)

^e UNIVERSITY OF IOANNINA   (Greece)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^g UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^h KLINIKUM MINDEN   (Germany)

ⁱ HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Acute stroke; Analysis; Benefit to risk ratio; Reperfusion therapies

Indexed keywords

ALTEPLASE; TENECTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

BIBLIOGRAPHIC DATABASE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMPARATIVE EFFECTIVENESS; FUNCTIONAL ASSESSMENT; HUMAN; INTRACRANIAL RETRIEVER DEVICE; MECHANICAL THROMBECTOMY; META ANALYSIS; MORTALITY; MULTICENTER STUDY (TOPIC); NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PERCUTANEOUS THROMBECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; REPERFUSION; REVIEW; RISK BENEFIT ANALYSIS; SONOTHROMBOLYSIS; TIME TO TREATMENT; TREATMENT OUTCOME; CLINICAL TRIAL (TOPIC); PROCEDURES; RISK ASSESSMENT; STROKE; ULTRASOUND THERAPY;

BRAIN ISCHEMIA; CLINICAL TRIALS AS TOPIC; FIBRINOLYTIC AGENTS; HUMANS; REPERFUSION; RISK ASSESSMENT; STROKE; TISSUE PLASMINOGEN ACTIVATOR; ULTRASONIC THERAPY;

EID: 84907959562     PISSN: None     EISSN: 21623279     Source Type: Journal    
DOI: 10.1002/brb3.279     Document Type: Review

References (40)

1. Alexandrov, A. V. 2010. Current and future recanalization strategies for acute ischemic stroke. J. Intern. Med. 267:209-219.
2. Alexandrov, A. V., and K. Barlinn. 2012. Taboos and opportunities in sonothrombolysis for stroke. Int. J. Hyperthermia. 28:397-404.
3. Alexandrov, A. V., C. A. Molina, J. C. Grotta, Z. Garami, S. R. Ford, J. Alvarez-Sabin, et al. 2004. Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N. Engl. J. Med. 351:2170-2178.
4. Balami, J. S., R. Chen, B. A. Sutherland, and A. M. Buchan. 2013. Thrombolytic agents for acute ischaemic stroke treatment: the past, present and future. CNS Neurol. Disord. Drug Targets 12:145-154.
5. Barlinn, K., and A. V. Alexandrov. 2013. Sonothrombolysis in ischemic stroke. Curr. Treat Options Neurol. 15:91-103.
6. Barreto, A. D., and A. V. Alexandrov. 2012. Adjunctive and alternative approaches to current reperfusion therapy. Stroke 43:591-598.
7. Behrouz, R. 2014. Intravenous tenecteplase in acute ischemic stroke: an updated review. J. Neurol. 261:1069-1072.
8. Bivard, A., L. Lin, and M. W. Parsonsb. 2013. Review of stroke thrombolytics. J. Stroke 15:90-98.
9. Broderick, J. P., Y. Y. Palesch, A. M. Demchuk, S. D. Yeatts, P. Khatri, M. D. Hill, et al. 2013. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N. Engl. J. Med. 368:893-903.
10. Ciccone, A., L. Valvassori, M. Ponzio, E. Ballabio, R. Gasparotti, M. Sessa, et al. 2010. Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial. J Neurointerv. Surg. 2:74-79.
11. Ciccone, A., L. Valvassori, M. Nichelatti, A. Sgoifo, M. Ponzio, R. Sterzi, et al. 2013. Endovascular treatment for acute ischemic stroke. N. Engl. J. Med. 368:904-913.
12. Edwards, R., B. E. Wiholm, and C. Martinez. 1996. Concepts in risk-benefit assessment. A simple merit analysis of a medicine? Drug Saf. 15:1-7.
13. Furie, K. L., S. E. Kasner, R. J. Adams, G. W. Albers, R. L. Bush, S. C. Fagan, et al. 2011. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 42:227-276.
14. Furlan, A., R. Higashida, L. Wechsler, M. Gent, H. Rowley, C. Kase, et al. 1999. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282:2003-2011.
15. Guo, J. J., S. Pandey, J. Doyle, B. Bian, Y. Lis, and D. W. Raisch. 2010. A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group. Value Health 13:657-666.
16. Hennerici, M. G., R. Kern, and K. Szabo. 2013. Non-pharmacological strategies for the treatment of acute ischaemic stroke. Lancet Neurol. 12:572-584.
17. Khatri, P., S. D. Yeatts, M. Mazighi, J. P. Broderick, D. S. Liebeskind, A. M. Demchuk, et al. 2014. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol. 13:567-574.
18. Kidwell, C. S., R. Jahan, J. Gornbein, J. R. Alger, V. Nenov, Z. Ajani, et al. 2013. A trial of imaging selection and endovascular treatment for ischemic stroke. N. Engl. J. Med. 368:914-923.
19. Landry, A., M. Foran, and A. Koyfman. 2014. In patients with acute ischemic stroke, do different thrombolytic doses, agents, or routes of administration lead to different outcomes? Ann. Emerg. Med. 63:435-436.
20. Lapchak, P. A., K. Kikuchi, P. Butte, and T. Holscher. 2013. Development of transcranial sonothrombolysis as an alternative stroke therapy: incremental scientific advances toward overcoming substantial barriers. Expert Rev. Med. Devices 10:201-213.
21. Martinez-Sanchez, P., E. Diez-Tejedor, B. Fuentes, M. A. Ortega-Casarrubios, and W. Hacke. 2007. Systemic reperfusion therapy in acute ischemic stroke. Cerebrovasc. Dis. 24(Suppl 1):143-152.
22. Muir, K. W., C. J. Weir, G. D. Murray, C. Povey, and K. R. Lees. 1996. Comparison of neurological scales and scoring systems for acute stroke prognosis. Stroke 27:1817-1820.
23. Naylor, A. R. 2007. Time is brain!. Surgeon 5:23-30.
24. Nogueira, R. G., H. L. Lutsep, R. Gupta, T. G. Jovin, G. W. Albers, G. A. Walker, et al. 2012. Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 380:1231-1240.
25. Parsons, M., N. Spratt, A. Bivard, B. Campbell, K. Chung, F. Miteff, et al. 2012. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N. Engl. J. Med. 366:1099-1107.
26. PENUBRA Pivotal Stroke Trial. 2009. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 40:2761-2768.
27. Ricci, S., L. Dinia, M. Del Sette, P. Anzola, T. Mazzoli, S. Cenciarelli, et al. 2012. Sonothrombolysis for acute ischaemic stroke. Cochrane Database Syst. Rev. 10:CD008348.
28. Rother, J., G. A. Ford, and V. N. Thijs. 2013. Thrombolytics in acute ischaemic stroke: historical perspective and future opportunities. Cerebrovasc. Dis. 35:313-319.
29. Rubiera, M., and A. V. Alexandrov. 2010. Sonothrombolysis in the management of acute ischemic stroke. Am. J. Cardiovasc. Drugs. 10:5-10.
30. San Roman, L., V. Obach, J. Blasco, J. Macho, A. Lopez, X. Urra, et al. 2012. Single-center experience of cerebral artery thrombectomy using the TREVO device in 60 patients with acute ischemic stroke. Stroke 43:1657-1659.
31. Saqqur, M., G. Tsivgoulis, F. Nicoli, D. Skoloudik, V. K. Sharma, V. Larrue, et al. 2014. The role of sonolysis and sonothrombolysis in acute ischemic stroke: a systematic review and meta-analysis of randomized controlled trials and case-control studies. J. Neuroimaging 24:209-220.
32. Saver, J. L., R. Jahan, E. I. Levy, T. G. Jovin, B. Baxter, R. G. Nogueira, et al. 2012. Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet 380:1241-1249.
33. Shi, Z. S., D. S. Liebeskind, B. Xiang, S. G. Ge, L. Feng, G. W. Albers, et al. 2014. Predictors of functional dependence despite successful revascularization in large-vessel occlusion strokes. Stroke 45:1977-1984.
34. Smith, W. S., G. Sung, S. Starkman, J. L. Saver, C. S. Kidwell, Y. P. Gobin, et al. 2005. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 36:1432-1438.
35. Smith, W. S., G. Sung, J. Saver, R. Budzik, G. Duckwiler, D. S. Liebeskind, et al. 2008. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 39:1205-1212.
36. Tarr, R., D. Hsu, Z. Kulcsar, C. Bonvin, D. Rufenacht, K. Alfke, et al. 2010. The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe. J. Neurointerv. Surg. 2:341-344.
37. 1995. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med. 333:1581-1587.
38. Tsivgoulis, G., J. Eggers, M. Ribo, F. Perren, M. Saqqur, M. Rubiera, et al. 2010. Safety and efficacy of ultrasound-enhanced thrombolysis: a comprehensive review and meta-analysis of randomized and nonrandomized studies. Stroke. 41:280-287.
39. Wardlaw, J. M., P. Koumellis, and M. Liu. 2013. Thrombolysis (different doses, routes of administration and agents) for acute ischaemic stroke. Cochrane Database Syst. Rev. 5:CD000514.
40. del Zoppo, G. J., R. T. Higashida, A. J. Furlan, M. S. Pessin, H. A. Rowley, and M. Gent. 1998. PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators. Prolyse in Acute Cerebral Thromboembolism. Stroke 29:4-11.